DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

Oncothyreon, Inc. (NASDAQ: ONTY)

1.65 0.04 (2.48%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ONTY $1.65 2.48%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.62
Previous Close $1.61
Daily Range $1.57 - $1.66
52-Week Range $1.48 - $3.60
Market Cap $168.8M
P/E Ratio -2.52
Dividend (Yield) $0.00 (0.0%)
Volume 943,767
Average Daily Volume 990,632
Current FY EPS -$0.34

Sector

Healthcare

Industry

Drug Makers

Oncothyreon, Inc. (ONTY) Description

Oncothyreon Inc. is a clinical-stage biopharmaceutical company which is focused on the development of therapeutic products for the treatment of cancer. Website: http://www.oncothyreon.com/

News & Commentary

Why Oncotheryeon, Inc., OncoMed Pharmaceuticals, Inc., and Array BioPharma Inc. Stocks Jumped Today

Three biotechs climb after a competitor's trial success boosts hope across the HER-2 breast cancer treatment market

Oncothyreon (ONTY) Shares March Higher, Can It Continue? - Tale of the Tape

Oncothyreon (ONTY) Shares March Higher, Can It Continue? - Tale of the Tape

Oncothyreon Inc. (ONTY) in Focus: Stock Rises 6.3% - Tale of the Tape

Oncothyreon Inc. (ONTY) in Focus: Stock Rises 6.3% - Tale of the Tape

Benzinga's Top Initiations

Oncothyreon (ONTY) CEO Dr. Robert Kirkman on Q4 2014 Results - Earnings Call Transcript

UPDATE: Oncothyreon Shares Drop After Q4 Results

Oncothyreon Inc . (ONTY) Q4 2014 Results - Earnings Call Webcast

Should You Buy Oncothyreon Inc (ONTY) Ahead of Earnings? - Tale of the Tape

Weekly Analyst Highlights: Oil, Tesla On Readers' Minds

How Wall Street Is Reacting To The Pharmacyclics Rumor

Oncothyreon (ONTY) Stock a Solid Choice Right Now? - Tale of the Tape

See More ONTY News...

ONTY's Top Competitors

ONTY $1.65 (2.48%)
Current stock: ONTY
AMGN $162.59 (1.27%)
Current stock: AMGN
GILD $101.00 (-0.07%)
Current stock: GILD
BIIB $429.87 (0.22%)
Current stock: BIIB